HDL cholesterol: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (HDL cholesterol efflux capacity) |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[physiology]], '''HDL cholesterol''' ('''HDL''') is "cholesterol which is contained in or bound to high-density lipoproteins (HDL), including [[cholesterol ester]]s and free [[cholesterol]]."<ref>{{MeSH}}</ref> | In [[physiology]], '''HDL cholesterol''' ('''HDL''') is "cholesterol which is contained in or bound to high-density lipoproteins (HDL), including [[cholesterol ester]]s and free [[cholesterol]]."<ref>{{MeSH}}</ref> | ||
| Line 8: | Line 9: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 16:00, 24 August 2024
In physiology, HDL cholesterol (HDL) is "cholesterol which is contained in or bound to high-density lipoproteins (HDL), including cholesterol esters and free cholesterol."[1]
It is not clear whether insufficient HDL causes coronary artery disease[2] and raising the HDL does not seem to reduce coronary artery disease.[3]
Low HDL is part of hypoalphalipoproteinemia.
The HDL cholesterol efflux capacity, "the ability of HDL to accept cholesterol from macrophages, which is a key step in reverse cholesterol transport" may be a more important biomarker than the HDL level at predicting cardiovascular events.[4]
References
- ↑ Anonymous (2024), HDL cholesterol (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK et al. (2012). "Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.". Lancet. DOI:10.1016/S0140-6736(12)60312-2. PMID 22607825. Research Blogging.
- ↑ AIM-HIGH Investigators. Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P et al. (2011). "Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.". N Engl J Med 365 (24): 2255-67. DOI:10.1056/NEJMoa1107579. PMID 22085343. Research Blogging.
- ↑ Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE et al. (2014). "HDL cholesterol efflux capacity and incident cardiovascular events.". N Engl J Med 371 (25): 2383-93. DOI:10.1056/NEJMoa1409065. PMID 25404125. PMC PMC4308988. Research Blogging.